
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | 2026-04-20 | Ribeiro Ramiro | Chief Medical Officer | Sale | 2,437 | $15.00 | $37K | 0 | View ↗ | |
| 2026-03-16 | 2026-03-16 | Duker Jay S. | Director & President and CEO | Purchase | 1,500 | $13.15 | $20K | 100.7K | View ↗ | |
| 2026-03-04 | 2026-03-05 | Ribeiro Ramiro | Chief Medical Officer | Sale | 2,438 | $17.87 | $44K | 0 | View ↗ | |
| 2026-02-17 | 2026-02-18 | Ribeiro Ramiro | Chief Medical Officer | Sale | 2,437 | $15.00 | $37K | 0 | View ↗ |
No annual data found.
EyePoint (EYPT) Q1 2026 Earnings Transcript
EyePoint Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Ocular: SOL-1 Success Is Real, But Adoption Risks Keep Me At Hold
EyePoint targets wet AMD Phase III top line data mid-year while projecting cash runway into Q4 2027